Casein kinase iδ mutations in familial migraine and advanced sleep phase. by Brennan, KC et al.
UCSF
UC San Francisco Previously Published Works
Title
Casein kinase iδ mutations in familial migraine and advanced sleep 
phase.
Permalink
https://escholarship.org/uc/item/091594cc
Journal
Science translational medicine, 5(183)
ISSN
1946-6234
Authors
Brennan, KC
Bates, Emily A
Shapiro, Robert E
et al.
Publication Date
2013-05-01
DOI
10.1126/scitranslmed.3005784
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California

MIGRA INE
Casein Kinase Id Mutations in Familial Migraine
and Advanced Sleep Phase
K. C. Brennan,1,2* Emily A. Bates,3,4* Robert E. Shapiro,5* Jekaterina Zyuzin,1
William C. Hallows,3 Yong Huang,3 Hsien-Yang Lee,3 Christopher R. Jones,2
Ying-Hui Fu,3 Andrew C. Charles,1† Louis J. Ptáček3,6†
Migraine is a common disabling disorder with a significant genetic component, characterized by severe headache
and often accompanied by nausea, vomiting, and light sensitivity. We identified two families, each with a distinct
missense mutation in the gene encoding casein kinase Id (CKId), in which the mutation cosegregated with both the
presence of migraine and advanced sleep phase. The resulting alterations (T44A and H46R) occurred in the con-
served catalytic domain of CKId, where they caused reduced enzyme activity. Mice engineered to carry the CKId-T44A
allele were more sensitive to pain after treatment with the migraine trigger nitroglycerin. CKId-T44A mice also
exhibited a reduced threshold for cortical spreading depression (believed to be the physiological analog of migraine
aura) and greater arterial dilation during cortical spreading depression. Astrocytes from CKId-T44A mice showed
increased spontaneous and evoked calcium signaling. These genetic, cellular, physiological, and behavioral analyses
suggest that decreases in CKId activity can contribute to the pathogenesis of migraine.
INTRODUCTION
Migraine is a complex neurological disorder that affects 20 to 30% of
the population (1, 2). About one-third of patients with migraine ex-
perience aura: a visual, sensory, or language disturbance preceding the
migraine headache (3). Family and epidemiological studies provide
strong evidence for a genetic contribution to migraine, although envi-
ronmental factors also play a role (4, 5). Mutations in three different
genes have been identified to cause familial hemiplegic migraine, an
uncommon variant of migraine associated with unilateral weakness
(6–8). The genetic basis for common forms of migraine (with and
without aura) is less clear. Multiple susceptibility loci for migraine
have been identified (9–12), and a potassium channel gene has been
linked to migraine with aura in a single family (13). These studies sug-
gest that a variety of genetic alterations affecting various aspects of
brain excitability can lead to similar migraine phenotypes.
Here, we describe a family that presented for clinical evaluation of
familial migraine with aura. In addition to migraine, the family mem-
bers exhibited circadian patterns consistent with familial advanced
sleep phase syndrome (FASPS), in which individuals go to sleep un-
usually early in the evening and wake early in the morning. We identi-
fied a mutation (threonine to alanine, T44A) in casein kinase Id (CKId)
as a cause of FASPS in this family (14). CKId is a ubiquitous serine-
threonine kinase that phosphorylates the circadian clock protein Per2
and many other proteins involved in brain signaling (15). In vitro studies
showed that the T44A alteration in CKId resulted in reduced enzyme
function in vitro, and both mice and flies expressing the mutant allele
had significant sleep-wake cycle alterations (14). Given that migraine
with aura was a prominent component of the presenting phenotype
of the family in whom the CKId mutation was identified, we investi-
gated a potential role for CKId in migraine.
RESULTS
Human phenotypes
Fourteen members of the initial family with CKId allele–associated
FASPS (K5231) were available for structured interview, physical exam-
ination, and CKId genotyping, including four spouses of affected in-
dividuals with potentially affected offspring (Fig. 1A). The proband
(#33376) carried the CKId-T44A allele and met diagnostic criteria both
for FASPS and for migraine with aura (MA) by ICHD-2 (International
Classification of Headache Disorders, Second Edition) criteria (16).
Of the 13 other family members that we characterized, 5 individuals
carried the CKId-T44A allele, and all of these also met diagnostic crite-
ria for either MA or migraine without aura (MO). Three individuals
who were offspring of CKId-T44A allele carriers, but did not carry the
allele themselves, also met diagnostic criteria for MA (Fig. 1A).
The clinical characteristics of migraine for the CKId-T44A allele
carriers were unremarkable with respect to age of onset, time of day
of attack onset, duration and character of aura symptoms, presence of
cutaneous allodynia (the experience of innocuous touch as uncomfort-
able or tender), and duration of headache per attack. The proband
(#33376) developed chronic migraine (more than 15 headache days
per month) from her early 20s through her early 30s and then again
between her early 40s and her early 50s with spontaneous remission
each time. Brain magnetic resonance imaging studies for three individ-
uals (#33373, #33374, and #33376) were unremarkable apart from
evidence of a previous pituitary tumor excision in #33373. The proband’s
mother (#33374) had French-Canadian ancestry.
After identifying CKId-T44A in K5231, we sequenced the gene en-
coding CKId in blood samples from more than 70 FASPS probands
and identified a second mutation in a single individual (#35315 in
kindred 5579) that predicts a histidine-to-arginine change at position
46 (H46R) (Fig. 1B and fig. S1), two amino acids downstream from
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the T44A substitution. This family is primarily of English and Irish
descent. Information regarding the migraine phenotype in the family
with the H46R mutation was obtained by an e-mail survey and by
follow-up e-mail or phone contact. Phenotypic data were analyzed blind
to genotypes and FASPS phenotypes. Four of the five family members
who carried the H46R allele had MO, MA, or migraine aura without
headache, and the fifth had probable migraine by ICHD-2 criteria. Of
five family members who did not carry the H46R allele, one had MA.
We examined the 1000 Genomes database, National Heart, Lung, and
Blood Institute (NHLBI) ESP6500 variant data set, and 69 public ge-
nomes from Complete Genomics for the T44A and H46R alleles that
we had identified in the migraine families and found neither allele in
these controls. No other coding variants in the first 200 amino acids of
CKId were found in Caucasian samples available in public databases.
We also sequenced DNA from an additional 250 Northern European
controls from our laboratories and found these alleles in none of them.
Furthermore, the protein sequences of CKId are extremely conserved
across species from human to fruit fly to single-cell algae, and T44 and
H46 are absolutely conserved (fig. S1). Thus, these two CKId alleles
were not present in more than 2600 control chromosomes. We esti-
mate that the chances of coincidentally having mutations in the same
ultraconserved region in two families with
the same phenotype are extremely small.
We previously showed that the CKId-
T44A protein has reduced kinase activity
in comparison to the wild-type enzyme
(14). We repeated these experiments for
the CKId-H46R isoform (Fig. 1C). CKId-
H46R also showed decreased kinase activ-
ity with a Vmax of (mean ± SEM) 104.64 ±
6.61 nM min−1 nM−1 compared to 198.27 ±
11. 23 nMmin−1 nM−1 for the wild-type en-
zyme, representing a 53% reduction in activ-
ity (P < 0.01, n = 3). The Michaelis constant
(Km) was 43.38 ± 6.17 mM for CKId-H46R
and 36.48 ± 7.79 mM for wild-type CKId
(Table 1). This decrease in Vmax suggests
that the mutation causes a reduction in the
catalytic rate of phosphotransfer. There may
be a subtle effect on enzyme recognition of
the substrate as the Km of the mutant ki-
nase activity is decreased with PER2 peptide
but is not significantly different with casein
or adenosine triphosphate (ATP). We also
tested the ability of wild-type and mutant
forms of CKId to phosphorylate connexin43,
a known substrate hypothesized to be rele-
vant to migraine (17). Both the T44A and
H46Rmutant forms of CKId phosphorylated
connexin43 to a lesser degree than did wild-
type CKId (Fig. 1, D and E).
Increased nitroglycerin-induced
hyperalgesia in CKId-T44A mice
To further examine whether mutant CKId
can cause migraine symptoms, we tested
CKId-T44A transgenic mice for their sus-
ceptibility to a migraine-like phenotype.
Nitroglycerin (NTG) evokes peripheral mechanical and thermal hyper-
algesia in mice and humans (18, 19). We quantified NTG-evoked
mechanical and thermal hyperalgesia in CKId-T44A mice and wild-
type littermate controls. Mechanical and thermal nociception thresh-
olds were determined with von Frey filaments and the Hargreaves
radiant heat assay, before and for a 4-hour period after intraperitoneal
injection of NTG (1, 3, 5, 7, or 10 mg/kg). During the 4-hour follow-
up, the mechanical thresholds were significantly lower in CKId-T44A
mice than in wild-type controls (n = 14 wild-type and 15 CKId-T44A,
P < 0.01 for each dose with a linear mixed-effects model; Fig. 2 and table
S1). After NTG injection, CKId-T44A mice were also more sensitive to
thermal stimuli than wild-type siblings, with a significantly slower re-
covery from thermal hyperalgesia (n = 24 CKId-T44A and n = 21 wild-
type mice; P < 0.01 for each dose with a linear mixed-effects model;
Fig. 2 and table S2). Because migraine is more common in women than
men, we compared female and male CKId-T44A mice with wild-type
animals 90 min after NTG (5 mg/kg) injection. At this dose and time
point, female, but not male, CKId-T44A mice showed a significant re-
duction in latency to paw withdrawal compared to wild-type animals
(males: wild-type, 0.99 ± 0.69 s; CKId-T44A, 2.46 ± 0.7 s; P = 0.38;
females: wild-type, 0.69 ± 0.75 s; CKId-T44A, 2.87 ± 0.58 s; P = 0.008,
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Fig. 1. Migraine kindreds with mutations in the gene encoding CKId and in vitro enzymatic anal-
ysis. (A) Kindred 5231 segregating the T44A CKId allele. (B) Kindred 5579 segregating the H46R CKId
allele. Phenotypes are as noted, and probands are indicated by arrows. “Migraine” indicates symptoms
consistent with ICHD-2 migraine without aura. “Aura” indicates symptoms consistent with ICHD-2 mi-
graine aura. (C) Saturation kinetic analysis of wild-type (•), T44A (□), and H46R (♦) CKIdD317 using a-
casein, PER2 peptide, and ATP. (D and E) Phosphorylation assays. Transiently transfected connexin43
is phosphorylated when coexpressed with CKId wild type. FLAG-connexin43 was expressed alone or
with CKId wild type, T44A, and H46R in HEK293 cells. FLAG-connexin43 was immunoprecipitated by
anti-FLAG conjugated to agarose at 4°C for 4 hours. These extracts were resolved by SDS–polyacrylamide
gel electrophoresis (SDS-PAGE), and phosphorylated and dephosphorylated connexin43 was detected
by Western blotting with anti-phosphoserine and anti-FLAG antibodies, respectively. Input blot pro-
teins were detected with anti-FLAG, anti-GFP (green fluorescent protein), and b-actin antibody. Relative
phosphorylation was normalized to connexin43 protein levels, quantified, and analyzed by LI-COR image
software. Data are means ± SEM (n ≥ 4). *P < 0.05, analysis of variance (ANOVA) followed by Tukey test.
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ANOVA with post hoc Tukey test), sug-
gesting that both sex and genotype may
contribute to the difference in thermal hy-
peralgesia. Rotarod testing showed no
difference in initial or repeat performance
for CKId-T44A mice and wild-type mice
(fig. S2), suggesting that differences in re-
sponse to thermal and mechanical stimula-
tion were not due to differences in motor
function or learning.
Neurons in the trigeminal nucleus
caudalis (TNC) and laminae I to V of up-
per cervical dorsal horn (C1 and C2) re-
ceive craniofacial pain input and are believed
to be activated during migraine (20–23).
We administered NTG (5 mg/kg) to CKId-
T44A (n = 7) and wild-type littermates
(n = 6) and measured the number of acti-
vated neurons in TNC, C1, and C2 with
Fos immunohistochemistry. After NTG
treatment, we found a significant increase
in the number of Fos-positive nuclei in all
three areas in CKId-T44A animals compared
to wild-type littermates in TNC (mean ±
SEM, 34 ± 2 versus 11 ± 1), C1 dorsal horn
(33 ± 3 versus 17 ± 2), and C2 dorsal horn
(28 ± 2 versus 14 ± 2) (Fig. 3). The number
of Fos-positive nuclei was not significantly
different in laminae VI to X.
Reduced threshold for induction
of cortical spreading depression
in CKId-T44A mice
To investigate the effects of CKId mutations
on migraine-related cortical excitability,
we used optical imaging and electrophysio-
logical recording to measure cortical spread-
ing depression (CSD) in vivo in CKId-T44A
mice (Fig. 4, A and B). Potassium chloride
(KCl) was applied to the cortex at increas-
ing volumes until CSD was induced to determine the threshold for
evoking CSD (24). CSD thresholds were significantly lower in CKId-
T44A compared to wild-type mice (Fig. 4D). CSD velocities were similar
in both groups (Fig. 4C). After we determined these threshold values,
repeat inductions were performed at threshold stimulus every 10 min
for the next 60 min. Despite the difference in the thresholds, there was
no significant difference in the number of successful CSD inductions
between the two groups (Fig. 4), showing that the lower CSD thresh-
olds in CKId-T44A mice were reproducible over time. The number
of CSDs induced in response to a constant stimulus is also used to
Table 1. Biochemical characterization of the migraine-associated CKId mutant enzymes. n ≥ 3 independent experiments with three replicates
each; all measurements shown are ±SEM.
Substrate
a-Casein PER2 peptide ATP
Vmax (nM min
−1 nM−1) Km (mM) Vmax (nM min
−1 nM−1) Km (mM) Vmax (nM min
−1 nM−1) Km (mM)
Wild-type CKIdD317 198.3 ± 11.2 36.5 ± 6.2 184.0 ± 24.4 635.8 ± 131.4 71.7 ± 14.7 180.6 ± 80.1
CKId-T44AD317 130.3 ± 6.7* 29.4 ± 4.8 80.1 ± 12.6* 230.6 ± 76.5* 22.9 ± 0.4* 30.0 ± 2.2
CKId-H46RD317 104.6 ± 6.6* 43.4 ± 7.8 49.5 ± 8.8* 371 ± 120.4* 25.8 ± 3.2* 104.7 ± 33.3
*P < 0.05 (Student’s t test).
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Fig. 2. Differential effects of mechanical and thermal stimuli in response to NTG for wild-type
and CKId-T44A mice. Data shown (means ± SEM) were compared with a linear mixed-effects model.
Gray lines, wild type; black lines, CKId-T44A. Differences across time between CKId-T44A and wild type
are significant at each NTG dosage (P values displayed for each panel). Asterisks indicate time points
with significant difference between genotypes. (A and C) Mechanical hyperalgesia measured with von
Frey hair (Semmes-Weinstein monofilament). (B and D) Thermal hyperalgesia in CKId-T44A and wild-
type mice in response to NTG [5 mg/kg (B) or 10 mg/kg (D)] intraperitoneal injection, measured with
radiant heat assay (Hargreaves test). *P < 0.05 (see tables S1 and S2 for detailed data).
R E S EARCH ART I C L E
www.ScienceTranslationalMedicine.org 1 May 2013 Vol 5 Issue 183 183ra56 3
 
o
n
 M
ay
 1
, 2
01
3
st
m
.s
ci
en
ce
m
ag
.o
rg
D
ow
nl
oa
de
d 
fro
m
 
measure CSD susceptibility (25). During 60 min of continuous appli-
cation of KCl, CKId-T44A mice showed a significantly greater number
of CSD events than did wild-type mice (Fig. 4E).
Enhanced CSD-associated arterial dilation in
CKId-T44A mice
Meningeal and cortical surface arteries react to CSD (26, 27). Activa-
tion of perivascular nociceptive afferents has been proposed as a mech-
anism through which CSD activates the TNC (21, 23). Pre-CSD
baseline arterial diameter was the same in CKId-T44A and wild-type
mice (Fig. 5). In both CKId-T44A and wild-type mice, CSD was asso-
ciated with multiphasic changes in arterial diameter: an initial dilation
coincident with or ahead of the CSD wavefront, a constriction corre-
sponding to the tissue depolarization, and a second dilation before a
return toward baseline (27) (Fig. 5). Cortical surface arteries were more
dilated in all phases of CSD in CKId-T44A mice compared with wild-
type mice (Fig. 5C). We found no correlation between the magnitude
of CSD-associated changes in vascular caliber and CSD threshold (177
diameter measurements in 15 mice where such measurement was
possible: dilation 1: r = −0.009, t = 0.11, tcrit = 1.97, P = 0.9; constriction:
r = 0.11, P = 0.13; dilation 2: r = 0.02, P = 0.69; post-CSD baseline: r =
−0.006, P = 0.92), suggesting that these vascular differences were not
due to the lower CSD thresholds in CKId-T44A mice.
Amplitude, duration, and velocity of CSD. We compared the am-
plitude and duration of both intrinsic signal and electrophysiological
variables associated with CSD in CKId-T44A and wild-type mice
(table S3). There was no significant difference in intrinsic signal or dc (di-
rect current) shift amplitude. Although the durations of intrinsic signal
changes and dc shifts were significantly shorter in CKId-T44Amice, there
was a significant correlation between duration of dc shift and CSD thresh-
old in all mice (r = 0.6, t = 3.83, tcrit = 2.05, P = 0.0007, n = 25 mice) and
in CKId-T44A and wild-type mice considered separately (CKId-T44A:
r = 0.56, t = 2.68, tcrit = 2.13, P = 0.02, n = 17 mice; wild type: r = 0.65,
t = 2.56, tcrit = 1.83, P = 0.03) (fig. S4). We ascribed this difference in du-
ration to the significant difference in thresholds between the two groups.
The velocity of CSD was similar between CKId-T44A and wild-type
mice, with no significant difference detected (Fig. 4C).
Sex differences in CSD susceptibility. We previously identified
a reduced threshold for CSD in female compared to male C57Bl/6 mice
(24), and others have found a reduced CSD threshold in female mice
expressing familial hemiplegic migraine mutations (28). We observed a
gradient of CSD thresholds by sex and genotype, with the lowest
thresholds in female CKId-T44A and the highest in male wild-type ani-
mals (fig. S3). ANOVA analysis of CSD thresholds by gender and geno-
type revealed a significant difference over the four combinations (female
CKId-T44A, male CKId- T44A, female wild-type, and male wild-type;
one-way ANOVA, F = 3.74, Fc = 2.70, P = 0.01). Post hoc Tukey test
showed that the only significantly different paired comparison was be-
tween female CKId-T44A and male wild-type mice. We concluded that,
although there may be a trend toward sex differences in our data set,
the main driver of differences was genotype.
Calcium signaling in astrocytes from CKId-T44A mice
Astrocyte Ca2+ signaling occurs in conjunction with CSD and may me-
diate some of the vascular changes associated with CSD (29). The
primary connexin expressed by astrocytes, connexin43, is a mediator
of astrocyte signaling and can be modulated by CKId (30). We found
that a greater number of cultured astrocytes from CKId-T44A mice
showed spontaneous Ca2+ oscillations and intercellular Ca2+ waves
than did astrocytes from wild-type mice (Fig. 6). We also investigated
the effects of exposure to medium without extracellular Ca2+ (0 Ca2+),
a condition that evokes intercellular waves of increased intracellular
Ca2+ in astrocytes by causing release of ATP (31, 32). Astrocytes from
CKId-T44A mice showed an increased Ca2+ response to 0 Ca2+ medium
compared to wild-type astrocytes, with a greater number of sites of ini-
tiation of intercellular Ca2+ waves and a greater extent of propagation
of intercellular Ca2+ waves (Fig. 6, B and C). We did not, however,
detect a significant increase in ATP release to this stimulus in astrocytes
from CKId-T44A mice (fig. S5).
DISCUSSION
We identified two distinct missense mutations in the gene encoding
CKId that cosegregated with migraine in two independent families with
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Fig. 3. NTG-induced Fos expression in the spinal cord and TNC. (A)
Quantification of Fos-immunoreactive nuclei in the cervical spinal cord
lamina I to V, VI to X, and TNC in age-matched wild-type (n = 6) and
CKId-T44A transgenic (n = 7) mice 2 hours after treatment with systemic
NTG (5 mg/kg). Data are expressed as average numbers of Fos+ cells
per section. *P < 1 × 10−5, two-way Student’s t test. (B and C) Repre-
sentative sections showing Fos immunoreactivity in wild-type (B) and
CKId-T44A (C) TNC.
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advanced sleep phase syndrome. The mutations (T44A and H46R)
occur in a conserved catalytic domain and reduce CKId kinase activity
compared to wild-type. Mice expressing the CKId-T44A allele are
more sensitive to pain and have increased activation of neurons in the
TNC after treatment with a common migraine trigger, NTG. CKId-
T44A mice also show a reduced threshold for CSD, increased frequen-
cy of CSD episodes, and greater arterial dilation with CSD. Astrocytes
from CKId-T44A mice show increased spontaneous and evoked cal-
cium signaling.
Migraine is frequent (~12% prevalence) in the general population,
and it is unclear at this point what underlying genetic variants con-
tribute to this frequency. Multiple loci that increase susceptibility to
migraine have been identified (9–11, 13), and environmental factors
could also play a role. In some cases, migraine is almost certainly caused
by common complex genetic risk alleles segregating in the population.
It is also possible that some alleles are autosomal dominant or auto-
somal recessive, but can be difficult to recognize as such because of
polygenic genetic risk alleles segregating in the same families harbor-
ing the Mendelian alleles. This may be the case for the kindred reported
here in which there are individuals with migraine who did not carry
the migraine-associated CKId allele.
Of 11 mutation carriers, 10 were classified as affected and 1 was
classified as probably affected. Comparison of the number of mutant
allele carriers with migraine (10 of 11) to the noncarriers with migraine
(5 of 13) using a Fisher’s exact test yielded a P value of 0.011. One would
not expect association of CKId alleles with migraine at that high fre-
quency by chance. Nonetheless, the fact that migraine occurred in some
family members who did not express a mutant CKId allele suggests
that each family may have other predispositions to the condition.
The association between two independent mutant CKId alleles and
the migraine phenotype suggests that these mutations contribute to
the pathogenesis of migraine. Further strengthening this argument are
in vitro and in vivo mouse data that support a possible causative role
of these variants in migraine.
Migraine is associated with increased sensitivity to all sensory mo-
dalities, and there is growing evidence that cutaneous allodynia is a
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Fig. 4. Increased susceptibility to CSD in CKId-T44A mice. (A) Normal-
ized reflectance images (r/r0 × 100) show CSD-associated optical intrinsic
signal (OIS) changes in a CKId-T44A mouse brain. KCl-induced CSD causes
changes in reflectance that propagate concentrically outward from the
source at about 3 mm/min. Reduced reflectance precedes brightening,
followed by profound darkening (image 4) before return toward baseline.
Reduced arterial reflectance shows the arterial dilation (arrows) that pre-
cedes CSD. Numbers indicate the seconds after CSD induction. Scale bar,
500 mm. Gray circle, field potential electrode and optical measurement lo-
cation. (B) OIS and field potential traces from the same experiment as in
(A), showing OIS changes and the direct current field potential shift of CSD.
OIS trace shows percentage change from pre-CSD. (C) CSD velocity in
CKId-T44A mice and wild-type (WT) littermates. Median [interquartile range
(IQR)] velocity was 2.7 mm/min (2.0 to 3.0 mm/min) in wild-type littermates
and 2.6 mm/min (2.3 to 3.2 mm/min) in CKId-T44A mice (n = 6 wild-type
mice, 17 CSD; 9 CKId-T44A mice, 29 CSD; P = 0.77, Mann-Whitney-Wilcoxon
test). (D) Threshold for CSD in wild-type and CKId-T44A mice. Median (IQR)
threshold was 0.28 ml (0.2 to 0.49 ml) of 1 M KCl in wild-type littermates
compared to 0.20 ml (0.14 to 0.35 ml) for CKId-T44A mice (n = 11 wild-type
mice, 43 CSDs; 14 CKId-T44A mice, 55 CSDs; P = 0.001, Mann-Whitney-
Wilcoxon test). There was no significant difference in the ratio of successful
CSD inductions in wild-type (3.90:6) versus CKId-T44A (3.92:6) mice (n = 11
wild-type, 14 CKId-T44A mice; P = 0.34, Mann-Whitney-Wilcoxon test). (E)
Elicitation of CSD in response to constant stimulation over an hour in
CKId-T44A mice and their wild-type littermates. Wild-type mice had median
(IQR) of 8.0 CSD/hour (6.5 to 9.25 CSD/hour) and CKId-T44A mice had 9.5
CSD/hour (8.75 to 12.75 CSD/hour) (n = 6 wild-type mice, 10 CKId-T44A mice;
P = 0.03, Mann-Whitney-Wilcoxon test).
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quantifiable marker of the disorder (33, 34). Hyperalgesia evoked
by the migraine trigger NTG in mice is a model for this allodynia
(19). Increased NTG-evoked mechanical and thermal hyperalgesia ex-
hibited by CKId-T44Amice is consistent with a role for CKId in sensory
hypersensitivity that is relevant to migraine. Increased NTG-induced
activation of c-fos–positive nuclei in the trigeminal dorsal horn of CKId-
T44A mice indicates increased activation of neurons associated with
craniofacial pain in comparison to wild type (21, 35). CKId-T44A mice
thus show both behavioral and functional anatomical evidence of al-
tered craniofacial nociception.
CKId-T44A mice showed both a significant reduction in the thresh-
old for evoking CSD and an increased number of CSD events eli-
cited by continuous stimulation, consistent with increased cortical
excitability that has been observed in patients with migraine. A similar
susceptibility to CSD has been observed in mice expressing mutations
in a P/Q-type Ca2+ channel and a Na+/K+ adenosine triphosphatase
that are responsible for familial hemiplegic migraine types I and II,
respectively (28, 36, 37). In addition to the difference in the suscep-
tibility to CSD, the cortical vascular response to CSD is altered in
CKId-T44A mice. Cortical and meningeal vessels contain trigeminal
afferents and transmit nociceptive signals (21, 23); the altered vascular
response to CSD in CKId-T44A mice could be relevant to migraine-
related pain.
Increased spontaneous and evoked Ca2+ signaling in astrocytes from
CKId-T44A mice compared to wild-type mice suggests that alteration in
astrocyte signaling could be a mechanism by which the CKId-T44Amu-
tation influences cortical excitability and associated vascular responses.
Astrocyte Ca2+ waves are consistently observed in conjunction with
CSD (29, 38, 39), and astrocyte signaling plays an important role in
neurovascular coupling (40). Astrocytes release extracellular messengers
including ATP and glutamate through undocked connexin channels
(hemichannels) (31, 41). Hypophosphorylation of connexin43 in-
creases the proportion of connexin molecules existing as hemichan-
nels in astrocytes compared with gap junctions, potentially leading to
increased release of ATP and glutamate (30, 31, 41). We showed that
connexin43 was hypophosphorylated by both mutant forms of CKId
(Fig. 1) and that spontaneous and induced calcium signaling (Fig. 6),
but not ATP release (fig. S5), was greater in cultured CKId-T44A astro-
cytes compared to wild type. Together, these findings suggest possible
astrocytic mechanisms by which CKId mutations could predispose to
migraine.
The relationship between the sleep phenotype and the migraine
phenotype in individuals with alterations in the function of CKId is
uncertain. Migraine can be modulated by sleep, and associations be-
tween migraine and a number of different sleep disorders have been
reported (42). Mice expressing mutant alleles responsible for familial
hemiplegic migraine type 1 have a circadian phenotype consisting of
enhanced circadian phase resetting (43). Common cellular mecha-
nisms may be involved in circadian function and episodic changes
in brain excitability that cause migraine. On the other hand, migraine
has not been reported as a part of the phenotype of other families with
FASPS, indicating that the mechanisms underlying the migraine pheno-
type in families with CKId mutations may be distinct from those that
cause alterations in sleep. Another interpretation is that CKId mutant
families have a genetic background that enhances susceptibility to sleep
phase–associated migraine triggers.
In summary, we have shown that mutations in CKId may contrib-
ute to the pathogenesis of human migraine and that mice expressing
the CKId-T44A mutant enzyme show phenotypic features resembling
those seen in the human disorder. The proteins encoded by all previ-
ously identified migraine genes are ion channels or pumps. CKId, in
contrast, is an enzyme that modulates the functions of a variety of
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Fig. 5. Increased dilation and decreased constriction to CSD in CKId-
T44A mice. (A) Arterial diameter changes in wild-type and CKId-T44A mice
during CSD. Kymographs reveal arterial diameter changes during acute CSD.
CSD is associated with arterial dilation that precedes the parenchymal CSD
wavefront (Fig. 4A), followed by constriction, a second dilation, and a post-
CSD dilation. Scale bar, 25 s, 125 mm. (B) The first image shows the line
drawn across the artery at baseline that generates CKId-T44A kymograph.
The following panels show each of the CSD-associated phases of arterial
activity. (C) Mean arterial diameter changes. Despite nearly identical baseline
diameters (26.4 ± 0.7 versus 26.3 ± 0.5 mm; P = 0.94) in wild-type and CKId-
T44A mice, dilation is more prominent and constriction is less marked in
CKId-T44A versus wild-type arteries. Initial dilation (32.2 ± 0.9 mm versus
35.6 ± 0.7 mm; P = 0.00008), second dilation (37.7 ± 1.3 mm versus 41.7 ±
1.0 mm; P = 0.002), and post-CSD (28.8 ± 0.8 mm versus 30.7 ± 0.8 mm; P = 0.01)
were all more dilated compared to baseline, and constriction was attenu-
ated (11.4 ± 1.0 mm versus 14.1 ± 0.9 mm; P = 0.02, linear mixed-effects
model with post hoc Tukey test) (wild type: n = 6 mice, 23 vessels, 67 mea-
surements; CKId-T44A: n = 9 mice, 34 vessels, 110 measurements).
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proteins, a subset of which could contribute to migraine pathogenesis.
Identifying protein targets of CKId that are relevant to migraine may
further elucidate the cellular signaling mechanisms underlying mi-
graine, and identify new therapeutic approaches.
MATERIALS AND METHODS
Genetic association
The family members originally sought medical attention for symp-
toms of migraine, but during the course of evaluation, multiple indi-
viduals were also diagnosed with advanced sleep phase syndrome.
Subjects signed consent or assent forms approved by the Institutional
Review Boards at the University of California at San Francisco (UCSF)
or the University of Utah. They then underwent physical and neuro-
logical examinations and structured interviews related to self-reported
migraine traits and symptoms, circadian and sleep traits, and general
health. Individuals were diagnosed with headache disorders according
to the criteria of the ICHD-2. Individuals not meeting either “affected”
or “unaffected” criteria were considered to be of “unknown” pheno-
type. Blood sample collection and DNA preparation were performed
as previously described (14).
Polymerase chain reaction and Sanger sequencing
of DNA samples
CKId was screened for mutations via Sanger sequencing of genomic
DNA. Genomic information of CKId coding regions was obtained
fromWeb site databases (National Center for Biotechnology Information:
http://www.ncbi.nlm.nih.gov/ and UCSC Genome Bioinformatics:
http://genome.ucsc.edu/) for primer design used for sequencing. Prim-
ers were designed outside of splice sites with the intent that intronic
sequencing of at least 50 base pairs would flank each exon border.
Twenty-five microliters of polymerase chain reactions (PCRs) was carried
out per 100 ng of genomic DNA and 10 pmol of both forward and re-
verse primers. PCR procedures that lead to successful product am-
plification were as follows: 98°C, 30 s (98°C, 10 s; 60°C, 30 s; 72°C,
40 s) × 35, 72°C, 10 min, and 4°C hold. PCR product purification was
done with the PCR96 Cleanup Plate (Millipore) and then sequenced. The
primer set used for sequenced exon 2 of CKId, which harbored the T44A
mutation, was as follows: forward primer, 5′-tgctaggaaggagaacacatcc-3′;
reverse primer, 5′-agctgtgactgctttgtcagg-3′.
Protein purification and kinetic analysis
Subcloning, site-directed mutagenesis purification of enzymes, and ki-
nase assays were performed as described (14). Briefly, reactions were
conducted in 50 mM Hepes (pH 7.5), 1 mM dithiothreitol, and 1 mM
MgCl2 at 25°C, with catalytic amounts of CKIdD317, CKIdD317 T44A,
or CKIdD317 H46R (10 to 20 nM), 3000 Ci/mmol [g-32P]ATP (1 to
500 mM), and substrate (1 to 500 mM, depending on the substrate,
a-casein or PER2 peptide). Five microliters of the reaction mixture
was spotted onto P81Whatman paper and washed with 1% phosphoric
acid. Radioisotope incorporation was assayed by exposure to phosphor-
image screen and quantified on a Typhoon image scanner. Satura-
tion experimental data were fit to the Michaelis-Menten equation with
KaleidaGraph (Synergy Software), and parameters kcat and Km were
determined.
Cell culture and transfection
Human embryonic kidney (HEK) 293 cells were cultured as a mono-
layer in Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal bovine serum (FBS). Cotransfection of HEK293 cells was
performed with 4 mg of total DNA with Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s protocol and as described in the figure
legend. Cell treatments were carried out as described in the figure
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Fig. 6. Increased spontaneous
and evoked calcium signal-
ing inCKId-T44Aastrocyte cul-
tures. (A) Each image shows a
600 × 600–mm field of cultured
cortical astrocytes. Change in
fluo4 fluorescence from base-
line is represented by grayscale.
Darker gray indicates increase
in intracellular Ca2+ concentra-
tions. Astrocytes from CKId-T44A
mice show increased spontane-
ous and 0Ca2+–evoked signaling
compared with those from wild-
typemice. Scale bar, 100 mm. (B) Raster plots showpattern of Ca2+ signaling
changes at baseline and upon exposure to 0 Ca2+ medium in wild-type
(left) and CKId-T44A (right) astrocyte cultures. Traces (above raster plots)
show the calcium response of a representative cell (indicated by asterisks)
in wild-type and CKId-T44A cultures. (C) Average number of cells in a 600 ×
600–mm field of cultured cortical astrocytes that show an increase in intra-
cellular Ca2+ concentrations during 2min under basal conditions (spontane-
ous) or during exposure to 0 Ca2+ medium (evoked). Error bars represent
SEM. Significantly more astrocytes from CKId-T44A show spontaneous (P =
0.0008) and 0 Ca2+–evoked increases in intracellular Ca2+ concentrations
compared to wild-type mice (P = 0.0006) [n = 16 cultures, 200 cells per
culture from eight different CKId-T44A mice, and 12 cultures, 200 cells per
culture from six different wild-type mice (two-tailed t test for samples of un-
equal variance for each comparison)].
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legends. Soluble cell extracts were made in radioimmunoprecipitation as-
say buffer (Sigma) with PhosSTOP and Complete tabs (Roche). Protein
concentration was quantified by Bradford assay (Bio-Rad).
Immunoprecipitation and Western blotting
Immunoprecipitations were performed with anti-FLAG antibody–
conjugated agarose resin (Sigma) as described by the manufacturer.
Western blotting and PAGE were carried out with standard protocols.
Animal care and handling
All protocols were approved by the Institutional Animal Care and Use
Committees at UCSF and UCLA. Experiments were conducted on CKId-
T44A line 827 (14) mice weighing between 20 and 30 g and their wild-
type littermates. Animals were housed in temperature-controlled rooms
on a 12-hour light-dark cycle. Experimenters were blind to the animal
genotypes in all experiments.
Nociception experiments
NTG administration. A stock of NTG (5 mg/ml) (American Regent
Inc.) dissolved in 30% alcohol, 30% propylene glycol, and water was
further diluted fresh each day in 0.9% saline in a polypropylene tube
to reach desired concentrations. Doses of 1, 3, 5, 7, or 10 mg/kg were
administered intraperitoneally, with a polypropylene syringe to mini-
mize the loss of NTG activity. Control mice received an intra-
peritoneal injection of 0.9% saline solution without NTG.
Behavioral assays. Animals were habituated to each testing ap-
paratus for 60 min on the day before and again immediately before
determination of baseline nociceptive thresholds. Each set of ani-
mals underwent nociception assay before and after application of
a specific dose of NTG. Behavioral assays were conducted blind to
the animal genotype.
Mechanical hypersensitivity testing. The von Frey (Semmes-
Weinstein) monofilament method was used to test mechanical sensi-
tivity. Animals were placed on a wire mesh stand, whereas calibrated
Semmes-Weinstein monofilaments (North Coast Medical) were used
for the up-and-down method of determining mechanical sensation of
each hind paw before injection (baseline) and 1, 2, and 4 hours after
NTG injection (44). Fourteen wild-type and 15 CKId-T44A animals
were tested. Left and right paws were scored separately for two read-
ings per mouse per time point. Mice were given 1 hour in home cages
with food and water immediately after the 2-hour measurement and
were tested again 4 hours after NTG as approved by the Institutional
Animal Care and Use Committees of responsible institutions.
Thermal hypersensitivity testing. To determine thermal hyper-
sensitivity, the radiant heat (Hargreaves) assay focuses radiant light on
the hind paw and measures the time in seconds until the mouse re-
moves each hind paw from the source of heat (PAW Thermal Stimu-
lator, UCSD Department of Anesthesia) (19, 45). Three determinations
of response were taken for every time point with at least 2 min between
each trial. The Hargreaves assay measured thermal nociceptive behav-
iors immediately before and 30, 60, 90, 120, and 240 min after injection
of NTG. Mice were returned to home cages for 1 hour after the 2-hour
measurement and were acclimated to the Hargreaves apparatus for
1 hour again before the 4-hour time point. Twenty-four CKId-T44A
mice were tested and 22 wild-type siblings were tested for doses of 1,
3, 5, 7, and 10 mg/kg. NTG thermal sensitivity experiments were re-
peated with one dose (5 mg/kg) at one time point (90 min) with 12
female CKId-T44A and 12 wild-type siblings.
Rotarod testing. Nine mice of each genotype (CKId-T44A mice
and wild-type littermates) were tested for motor function and learning
on the rotarod (46). The rotating rod attained a speed of 40 rpm over
a period of 5 min. Three trials separated by 1 min each were completed
in each set. Each animal underwent three sets of trials for a total of nine
trials. Animals were given 15-min rest between each set of the tests.
Immunohistochemistry
CKId-T44A and wild-type littermates were treated with intraperi-
toneal injection of NTG (5 mg/kg). Two hours after NTG, mice were
deeply anesthetized with isoflurane and perfused intracardially with
phosphate-buffered saline (PBS) and then 4% paraformaldehyde.
Whole brain and spinal cord were fixed overnight in 4% paraformal-
dehyde and transferred to 30% sucrose in PBS at 4°C until sectioning.
Transverse 35-mm sections of frozen spinal cord and brain were cut.
Free floating sections were incubated in PBS and 0.3% Triton X-100
and 5% normal goat serum (NGS-T) for 1 hour before incubation in
primary anti-Fos (Oncogene Science) at a dilution of 1:40,000 in 5%
NGS-T for 18 hours at 4°C. Sections were washed in PBS before in-
cubation for 1 hour in biotinylated goat anti-rabbit antibody (Vector
Laboratories), washed in PBS, and incubated in ExtrAvidin-Peroxidase
(Sigma-Aldrich Biotechnology) for 1 hour, followed by detection of
the peroxidase with 3,3′-diaminobenzidine (Sigma).Mounted and cover-
slipped sections were counted for Fos-reactive nuclei by a single blinded
observer. Fos-positive cells were counted in TNC, C1 dorsal horn, or C2
dorsal horn in 6 to 10 sections per animal (n = 6 wild-type and 7 CKId-
T44A mice). Sections were excluded if the tissue was torn or damaged.
Sections were visualized with an Olympus CX41 upright light micro-
scope. Photographs were taken with a PixeLINK PL-A662 and captured
with the PixeLINK Capture software. A two-tailed Student’s t test was
used to determine statistical significance.
CSD experiments
Anesthesia was induced (5%) and maintained (0.8 to 1.5%) with iso-
flurane. Temperature was maintained at 37 ± 0.5°C with a rectal tem-
perature probe and homeothermic blanket. A pulse oximetry probe
was placed on the right hindpaw (8600 V, Nonin), and hemoglobin
saturation was maintained at >95%. Anesthetic levels were adjusted to
maintain the animal in burst suppression on field potential recordings,
with an interburst interval of 4 to 9 s (47). At this anesthetic depth, the
animal had no response to noxious stimulation. There were no signif-
icant differences in anesthetic level, temperature, hemoglobin saturation,
or field potential burst duration or interburst interval between wild-type
and CKId-T44A mice (P > 0.3 for all comparisons, Student’s t test).
Each animal was placed in a stereotaxic frame (Kopf Instruments),
and the parietal skull was exposed. The skull was thinned to transpar-
ency, to boundaries 1 mm from temporal ridge, sagittal suture, bregma,
and lambda. A glass recording electrode (~20-mm diameter, 1 M KCl fill
solution, ~0.5-megohm resistance) was advanced 550 mm into the cortex
through a burr hole placed 0.5 mm anteromedial to lambda to collect
field potentials. A silver-silver chloride ground wire was placed in the
neck musculature. A second burr hole was placed 0.5 mm from the tem-
poral ridge midway between bregma and lambda for CSD induction.
A 34-gauge fused silica micropipette filled with 1 M KCl and attached
to a pneumatic pico-pump (MicroFil and PV-820, WPI) was carefully
apposed to the cortex in the second burr hole.
The animal was placed on the imaging stage of a custom micro-
scope and rested under anesthesia for 1 hour before imaging. The cor-
R E S EARCH ART I C L E
www.ScienceTranslationalMedicine.org 1 May 2013 Vol 5 Issue 183 183ra56 8
 
o
n
 M
ay
 1
, 2
01
3
st
m
.s
ci
en
ce
m
ag
.o
rg
D
ow
nl
oa
de
d 
fro
m
 
tex was illuminated with white light (5500 K, 400- to 700-nm spectral
range, Philips Lumileds). Reflected light was collected for OIS with a
lens system consisting of two f/0.95 lenses connected front to front,
focused on a high-sensitivity (0.00015 lux) 8-bit charge-coupled device
camera (Watec 902K). Field of view was 4.2 × 3.2 mm, and pixel size
was 6.6 mm. Images were acquired at 2 Hz for 1 hour. Field potentials
were acquired (bandpass, 0 to 1 kHz), amplified (A-M Systems 3000),
digitized (at 1 kHz; PCI-6251, National Instruments), and recorded and
synchronized with imaging data by a custom LabView Virtual Instru-
ment (National Instruments).
CSD thresholding consisted of a series of pulses with progressively
increasing pressure ejecting increasing volumes of KCl from the pipette
(4 to 40 psi in 2-psi increments at 300-s intervals, corresponding to KCl
volumes of 0.2 to 1.4 ml) until threshold for CSD was achieved (24).
After determination of threshold, repeat inductions were performed
at threshold levels every 10 min for a total of six KCl ejections. Vol-
ume ejected from the KCl pipette was verified before and after each
experiment to ensure replicable thresholds. The KCl method of thresh-
olding was used because it allowed focal administration of the KCl
stimulus (electrical stimulation causes more diffuse activation and thus
arterial dilation, which impedes measurement of CSD-associated vas-
cular parameters). After thresholding, the animal was euthanized with
5% isoflurane followed by nitrogen asphyxia.
To test the rate of CSD in response to a constant stimulus, we
positioned the KCl pipette just over the burr hole without touching
the brain, and a 4-psi tonic output from the pneumatic pico-pump
produced a constant flow of 1 M KCl into the burr hole during the
course of an hour-long experiment.
Image analysis was performed with ImageJ [National Institutes of
Health (NIH), Bethesda, MD] and IGOR Pro (WaveMetrics). Normal-
ized reflectance images (r/r0 × 100) were generated by dividing each
frame by an average of the first 10 frames of the experiment. To gen-
erate an optical trace of CSD, we traced a 100-pixel curved line region
of interest (ROI) along the CSD wavefront at the point where it con-
tacted the field potential electrode. Each pixel of the ROI generated a
trace of the CSD waveform, synchronous with electrophysiological
changes, which could be compared with the other traces in each ex-
periment as well as with separate experiments. Surface arteries were
identified by morphology and by reactivity to CSD, as previously de-
scribed (27). To sample vessels in an unbiased manner, we divided
each imaging field into quadrants. The arterial segment closest to
the center of each quadrant was chosen for analysis, yielding four ar-
terial ROIs per experiment. A 50-pixel (330-mm) line ROI was placed
perpendicular to the long axis of the vessel. When plotted over the
course of the experiment, this line ROI revealed the diameter of the ves-
sel, which could be computed via pixel count (Threshold and Measure
Functions, ImageJ). ROIs (6 × 6 pixels) were placed immediately adja-
cent to the line ROIs that were used to measure arterial diameter. These
allowed comparison of parenchymal and arterial changes in the same
location.
OIS and field potential amplitudes and durations were measured
after detecting the critical points in the respective intrinsic signal and
field potential traces. This was done by computing the second deriv-
ative of each data set, allowing points of maximum change in slope to
be identified. Five critical points were typically seen for intrinsic signal
data: at the onset of changes, at the minimum of the first phase, at the
maximum of the second phase, at the minimum of the third phase,
and during a return to baseline levels (Fig. 3B). Three critical points
were found for field potential data: at the onset, maximum, and recov-
ery of dc shift, respectively (Fig. 3B). OIS duration was calculated be-
tween the first and fourth critical points, and area under the curve was
computed separately for each phase using its boundary critical points.
dc shift duration was calculated between the first and third field
potential critical points, and amplitude was calculated between the
first and second critical points.
Calcium imaging of astrocytic cultures
Astrocyte cultures were prepared from 1-day postnatal mouse pups
(31). Cortices were removed, mechanically dissociated, and filtered
as above, but the cells were resuspended and plated on glass coverslips
in DMEM/F12 medium supplemented with 5% FBS. At days 4 to 7
in culture, cells were mechanically shaken for 30 min per day, and non-
adherent cells were removed. Cells were cultured for 14 days before
experimentation.
Changes in intracellular calcium concentration were recorded with
a custom confocal microscope as previously described (48). Briefly,
cells were loaded with the calcium indicator fluo4 by bath exposure
to 5 mM fluo4 acetomethoxy ester (Molecular Probes) for 30 min. Cells
were washed repeatedly to remove excess indicator and then placed on
the stage of amodifiedNikonDiaphotmicroscope (Nikon Instruments).
Excitation from a 475-nmdiode laser was scanned via resonancemirrors
to the coverslip through a 20 × 0.90 numerical aperture (Olympus) ob-
jective. Fluorescence emission was collected through a 535-nm bandpass
filter to a photomultiplier tube (Hamamatsu), and images were acquired
at 5 Hz at a pixel resolution of 940 × 720 by an image acquisition board
(Raven, BitFlow) controlled by Video Savant (IO Industries) software.
Solutions containing glutamate, N-methyl-D-aspartate (NMDA), or
0 Ca2+ were applied by bath exchange.
ROIs were placed on all cells in each microscopic field, and values
for fluo4 fluorescence versus time were determined for each cell in the
field for each experiment. Line traces and raster plots were generated
from normalized images (DF/F0).
ATP release
Assays of released ATP were performed with methods similar to those
previously described (31). Astrocyte cultures were prepared as above
and grown in plastic dishes. To measure basal ATP release, we re-
placed the medium above the cultures with 0.7 ml of Hanks’ balanced
salt solution (HBSS) for 1 min. This medium was then removed, im-
mediately frozen, and replaced with HBSS with no added Ca2+ and
Mg2+ for 1 min, after which this medium was also collected and frozen.
ATP assays were performed with the Enlighten assay kit (Promega)
with luminescence measurements performed with aWallac Victor plate
reader. The concentration of ATP released into normal medium in
1 min was subtracted from that released in low Ca2+/Mg2+ medium
in 1 min to determine the amount of stimulated ATP release.
Statistical testing
Unless otherwise noted, one-way ANOVA or Student’s t test was
used, after determination that data sets were parametric. Post hoc test-
ing was performed with Tukey test. Pearson’s test was used to assess
correlation between different CSD-associated measures. Statistical tests
were implemented in IGOR Pro 6.0 (WaveMetrics). Unless otherwise
noted, error bars denote SEM.
For nociception experiments, differences in response to mechanical
and thermal stimulation were examined with a linear mixed-effects
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model that accounted for both the correlation between repeated mea-
surements taken across time on each mouse and the correlation be-
tween repeated measurements taken at each time point. The means,
SEs, and differences of means reported in figures and in the text are
based on the mixed model. Tests of the genotype-by-time interaction
(P values in Fig. 2) assess the difference between CKId-T44A and wild
type across the time spectrum. Analyses were conducted with SAS
(version 9.3, SAS Institute Inc.).
SUPPLEMENTARY MATERIALS
www.sciencetranslationalmedicine.org/cgi/content/full/5/183/183ra56/DC1
Fig. S1. Alignments for Drosophila Dbt and mouse (m) and human (h) CKId and CKIe proteins.
Fig. S2. Motor function in wild-type and CKId-T44A mice.
Fig. S3. Gradient of CSD thresholds by sex and genotype.
Fig. S4. Scatterplot of CSD dc shift duration and threshold in all animals.
Fig. S5. Astrocyte ATP release evoked by low divalent cation solution.
Table S1. Mechanical sensitivity thresholds.
Table S2. Thermal responses.
Table S3. CSD-associated measures in CKId-T44A mice and wild-type littermates.
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